// App-Quantinova.ai

BSH19‐PO‐147 : Response to intravenous iron in the iron‐restricted population that are intolerant or refractory to oral iron

Researchers

Presenter

  • A. Korb

Principal Investigators

  • M. Bradbury

  • W. Thomas

Medical Centers

  • Peninsula Medical School

  • Department of Haematology, Plymouth Hospitals NHS Trust, Plymouth, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Chronic kidney disease

Biomarkers

  • N/A

Drug/Treatment

  • Ferric carboxymaltose

  • PR-21

Outcome

  • N/A

Study Design

  • Fixed Dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved